Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Michael Ellis (NPI 1598127243)

Field	Value
Entity Type	Individual
Organization	Michael Ellis
Address	8600 Quivira Rd Ste 100
City	Lenexa
State	KS
ZIP	66215
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 22, 2016

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

This provider’s billing mix is dominated by intravitreal anti‑VEGF injections: J0178 (injection, aflibercept) generated $793.3K in Medicare revenue across 1.1K claims (51.4% of the provider’s Medicare revenue), J2777 (faricimab) contributed $262.8K across 9.1K claims (17.0%), and J2778 (ranibizumab) added $145.3K across 812 claims (9.4%). These three drug codes are all retina‑focused biologic injections, indicating the practice operates primarily as a retina/injection clinic with medication administration as its core service line.

Revenue is highly concentrated: the top 3 Medicare codes account for 77.8% of the provider’s Medicare revenue, with a single code, J0178, alone representing 51.4% ($793.3K) of $1.5M in total Medicare revenue. That concentration implies most Medicare dollars flow from a narrow set of high‑cost intraocular biologic therapies rather than a broad mix of services.

Payer mix is effectively single‑payer Medicare: total Medicare revenue is $1.5M and there is no Medicaid billing on file, so Medicaid does not contribute to this provider’s documented public‑payer volume. Analysts should treat this profile as Medicare‑centric when assessing public‑payer exposure and reimbursement sensitivity.

Despite the heavy revenue concentration in drug administration, this provider’s national standing for the primary drug codes is modest: J0178 ranks #1135 of 3204 providers (65th percentile; typical, unremarkable volume), J2777 ranks #1072 of 2039 (47th percentile; typical, unremarkable volume), and J2778 ranks #504 of 1208 (58th percentile; typical, unremarkable volume). These percentiles suggest the provider is a routine national participant for these drugs rather than a dominant top‑tier injector.

Diagnostic imaging and retinal photography volumes are relatively high compared with national peers, supporting the injection‑centric model with comprehensive imaging capability: 92134 produced 1.6K claims and $43.2K (2.8% of Medicare revenue) and ranks #1409 of 26868 (95th percentile; notably above typical national volume), while 92250 delivered 549 claims and $13.2K (0.9%) and ranks #1016 of 25087 (96th percentile; notably above typical national volume). This combination of elevated retinal imaging and high injection revenue indicates an integrated clinic workflow that pairs frequent drug delivery with advanced imaging.

Office evaluation and management activity shows a mix of higher‑complexity new visits alongside typical established‑patient care: 99204 appears with 189 claims and $20.8K (1.3% of revenue) and ranks #5662 of 227068 (97th percentile; notably above typical national volume), while established visit codes 99214 and 99213 show typical volumes. The relatively high ranking for 99204 suggests the practice sees a steady stream of moderate‑complexity new patients, consistent with a specialty referral pattern.

Surgical retina procedures are present but are a minority of revenue and lower relative volume than injections: 67028 accounts for 1K claims and $91.9K (6.0% of Medicare revenue) and ranks #1326 of 4255 (69th percentile; typical, unremarkable volume), while other surgery codes (67108, 67042, 67036) show small claim counts and lower percentile rankings. Together these data point to occasional operative care on top of a primarily clinic‑based injection and imaging practice rather than a surgery‑focused practice.

The provider has an established Medicare billing history, with the NPI enumerated on 2016-03-22 (~10 years ago), which gives analysts nearly a decade of enrollment tenure to evaluate longitudinal patterns and stability in the injection‑centric revenue mix.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,150	$690	$793.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	9,060	$30	$262.8K
J2778	Injection, ranibizumab, 0.1 mg	810	$180	$145.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,040	$90	$91.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,600	$30	$43.2K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	290	$100	$28.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	310	$90	$28.6K
J3590	Unclassified biologics	310	$70	$21.1K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	190	$110	$20.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	180	$90	$16.4K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Michael Ellis — 3 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	18	30	1,770	$690	$1.3M
J2777	18	30	12,060	$30	$575.7K
J2778	13	20	860	$180	$297.6K
67028	20	40	1,170	$90	$111.4K
67042	18	20	20	$1,140	$31.9K
67108	11	20	20	$1,130	$24.8K
J3590	8	20	200	$100	$24.1K
67036	10	10	20	$930	$21.4K
92014	159	530	180	$70	$18.5K
99214	1,704	4,310	120	$70	$16.4K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Michael Ellis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Cincinnati Physicians Company, LLC	OH	Family Medicine Physician	$0	$65.2M
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Michael Ellis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bethesda Lutheran Communities	KS	Mental Illness Intermediate Care Facility	$0	$17.6M
Cherub Medical Supply, LLC	KS	Durable Medical Equipment & Medical Supplies	$0	$6.3M
Mawd Pathology Group Inc	KS	Anatomic Pathology & Clinical Pathology Physician	$660	$5.9M
Gregory Fox	KS	Ophthalmology Physician	$4M	$0
Ravi Singh	KS	Ophthalmology Physician	$3.9M	$0
Cpf Senior Living - Lenexa LLC	KS	Assisted Living Facility	$0	$3.8M
Beatty Suiter	KS	Ophthalmology Physician	$3.5M	$0
Ryan Christensen	KS	Ophthalmology Physician	$3.3M	$0
180 Medical, Inc.	KS	Durable Medical Equipment & Medical Supplies	$0	$2.7M
Midwest Division-oprmc LLC	KS	General Acute Care Hospital	$0	$2.6M

Michael Ellis — Billing Profile & Reimbursement Data

Sign up for Michael Ellis — Billing Profile & Reimbursement Data policy alerts

Michael Ellis — Billing Profile & Reimbursement Data

Sign up for Michael Ellis — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References